BANCHEREAU JACQUES F has a total of 19 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HLA G TECHNOLOGIES, SAN RAFFAELE CENTRO FOND and GOVERNMENT OF THE REPUBLIC OF SINGAPORE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 9 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Climate change adaptation technologies | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Banchereau Jacques F | 19 |
#2 | Zurawski Gerard | 8 |
#3 | Palucka Anna Karolina | 6 |
#4 | Oh Sangkon | 5 |
#5 | Montes Monica | 5 |
#6 | Zurawski Sandra | 5 |
#7 | Flamar Anne-Laure | 4 |
#8 | Li Dapeng | 3 |
#9 | Levy Yves | 3 |
#10 | Cobb Amanda | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010104748A2 | Antigen presenting cell targeted anti-viral vaccines | |
WO0129192A2 | Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |